Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Differential effects of Calca-derived peptides in male mice with diet-induced obesity.

Bartelt A, Jeschke A, Müller B, Gaziano I, Morales M, Yorgan T, Heckt T, Heine M, Gagel RF, Emeson RB, Amling M, Niemeier A, Heeren J, Schinke T, Keller J.

PLoS One. 2017 Jun 30;12(6):e0180547. doi: 10.1371/journal.pone.0180547. eCollection 2017.

2.

The activity of the serotonin receptor 2C is regulated by alternative splicing.

Stamm S, Gruber SB, Rabchevsky AG, Emeson RB.

Hum Genet. 2017 Sep;136(9):1079-1091. doi: 10.1007/s00439-017-1826-3. Epub 2017 Jun 29. Review.

3.
4.

Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing.

Ferrick-Kiddie EA, Rosenthal JJ, Ayers GD, Emeson RB.

Sci Rep. 2017 Feb 20;7:41095. doi: 10.1038/srep41095.

5.

Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake.

Zhang Z, Shen M, Gresch PJ, Ghamari-Langroudi M, Rabchevsky AG, Emeson RB, Stamm S.

EMBO Mol Med. 2016 Aug 1;8(8):878-94. doi: 10.15252/emmm.201506030. Print 2016 Aug.

6.

Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome.

Zhou C, Ding L, Deel ME, Ferrick EA, Emeson RB, Gallagher MJ.

Neurobiol Dis. 2015 Jan;73:407-17. doi: 10.1016/j.nbd.2014.10.021. Epub 2014 Nov 4.

7.

Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Hood JL, Morabito MV, Martinez CR 3rd, Gilbert JA, Ferrick EA, Ayers GD, Chappell JD, Dermody TS, Emeson RB.

Mol Cell Neurosci. 2014 Jul;61:97-109. doi: 10.1016/j.mcn.2014.06.001. Epub 2014 Jun 4.

8.

One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise.

Ulbricht RJ, Emeson RB.

Bioessays. 2014 Aug;36(8):730-5. doi: 10.1002/bies.201400055. Epub 2014 May 30.

9.

Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence.

Anastasio NC, Stutz SJ, Fox RG, Sears RM, Emeson RB, DiLeone RJ, O'Neil RT, Fink LH, Li D, Green TA, Moeller FG, Cunningham KA.

Neuropsychopharmacology. 2014 Jan;39(2):370-82. doi: 10.1038/npp.2013.199. Epub 2013 Aug 13.

10.

Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders.

O'Neil RT, Emeson RB.

Neurobiol Dis. 2012 Jan;45(1):8-13. doi: 10.1016/j.nbd.2011.08.026. Epub 2011 Sep 3. Review.

11.

Editing of neurotransmitter receptor and ion channel RNAs in the nervous system.

Hood JL, Emeson RB.

Curr Top Microbiol Immunol. 2012;353:61-90. doi: 10.1007/82_2011_157. Review.

12.

The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove.

Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, Allain FH.

Cell. 2010 Oct 15;143(2):225-37. doi: 10.1016/j.cell.2010.09.026.

13.

Impact of RNA editing on functions of the serotonin 2C receptor in vivo.

Olaghere da Silva UB, Morabito MV, Canal CE, Airey DC, Emeson RB, Sanders-Bush E.

Front Neurosci. 2010 Mar 16;4:26. doi: 10.3389/neuro.23.001.2010. eCollection 2010.

14.

Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.

Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB.

Neurobiol Dis. 2010 Aug;39(2):169-80. doi: 10.1016/j.nbd.2010.04.004. Epub 2010 Apr 13.

15.

High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles.

Morabito MV, Ulbricht RJ, O'Neil RT, Airey DC, Lu P, Zhang B, Wang L, Emeson RB.

Mol Pharmacol. 2010 Jun;77(6):895-902. doi: 10.1124/mol.109.061903. Epub 2010 Feb 24.

16.

An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain.

Lanfranco MF, Seitz PK, Morabito MV, Emeson RB, Sanders-Bush E, Cunningham KA.

J Neurosci Methods. 2009 May 15;179(2):247-57. doi: 10.1016/j.jneumeth.2009.01.027. Epub 2009 Feb 7.

17.

ADAR1 and ADAR2 expression and editing activity during forebrain development.

Jacobs MM, Fogg RL, Emeson RB, Stanwood GD.

Dev Neurosci. 2009;31(3):223-37. doi: 10.1159/000210185. Epub 2009 Mar 27.

18.

RNA editing as a therapeutic target for CNS disorders.

Morabito MV, Emeson RB.

Neuropsychopharmacology. 2009 Jan;34(1):246. doi: 10.1038/npp.2008.159. Review. No abstract available.

19.

Developmental modulation of GABA(A) receptor function by RNA editing.

Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB.

J Neurosci. 2008 Jun 11;28(24):6196-201. doi: 10.1523/JNEUROSCI.0443-08.2008.

20.

The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation.

Huebner AK, Keller J, Catala-Lehnen P, Perkovic S, Streichert T, Emeson RB, Amling M, Schinke T.

Arch Biochem Biophys. 2008 May 15;473(2):210-7. doi: 10.1016/j.abb.2008.02.013. Epub 2008 Feb 16. Review.

PMID:
18307972
21.

Mouse models to elucidate the functional roles of adenosine-to-inosine editing.

Rula EY, Emeson RB.

Methods Enzymol. 2007;424:333-67.

PMID:
17662849
22.

Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2.

Singh M, Kesterson RA, Jacobs MM, Joers JM, Gore JC, Emeson RB.

J Biol Chem. 2007 Aug 3;282(31):22448-59. Epub 2007 Jun 12.

23.

Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis.

Thompson BJ, Washington MK, Kurre U, Singh M, Rula EY, Emeson RB.

Dig Dis Sci. 2008 Jan;53(1):229-41. Epub 2007 May 26.

PMID:
17530400
24.

Calcitonin deficiency in mice progressively results in high bone turnover.

Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M.

J Bone Miner Res. 2006 Dec;21(12):1924-34.

25.

Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function.

Xu M, Wells KS, Emeson RB.

Mol Biol Cell. 2006 Jul;17(7):3211-20. Epub 2006 May 3.

26.

Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs.

Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH.

Structure. 2006 Feb;14(2):345-55.

27.

Altered RNA editing in mice lacking ADAR2 autoregulation.

Feng Y, Sansam CL, Singh M, Emeson RB.

Mol Cell Biol. 2006 Jan;26(2):480-8.

28.

Food fight: the NPY-serotonin link between aggression and feeding behavior.

Emeson RB, Morabito MV.

Sci STKE. 2005 Mar 29;2005(277):pe12. Review.

PMID:
15798100
29.

Resonance assignments of the double-stranded RNA-binding domains of adenosine deaminase acting on RNA 2 (ADAR2).

Stefl R, Skrisovska L, Xu M, Emeson RB, Allain FH.

J Biomol NMR. 2005 Jan;31(1):71-2. No abstract available.

PMID:
15692744
30.

Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.

Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M.

J Bone Miner Res. 2004 Dec;19(12):2049-56. Epub 2004 Sep 20.

31.

Structure and sequence determinants required for the RNA editing of ADAR2 substrates.

Dawson TR, Sansam CL, Emeson RB.

J Biol Chem. 2004 Feb 6;279(6):4941-51. Epub 2003 Nov 30.

32.

Modulation of RNA editing by functional nucleolar sequestration of ADAR2.

Sansam CL, Wells KS, Emeson RB.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14018-23. Epub 2003 Nov 11.

33.

Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve.

Maison SF, Emeson RB, Adams JC, Luebke AE, Liberman MC.

J Neurophysiol. 2003 Nov;90(5):2941-9. Epub 2003 Aug 6.

34.

RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.

Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP.

Br J Pharmacol. 2001 Sep;134(2):386-92.

35.

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E.

Neuropsychopharmacology. 2001 May;24(5):478-91.

36.

Functions and mechanisms of RNA editing.

Gott JM, Emeson RB.

Annu Rev Genet. 2000;34:499-531. Review.

PMID:
11092837
37.

Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development.

Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB.

Mol Cell Neurosci. 1999 Aug;14(2):99-120.

PMID:
10532808
39.

Regulation of alternative splicing by RNA editing.

Rueter SM, Dawson TR, Emeson RB.

Nature. 1999 May 6;399(6731):75-80.

PMID:
10331393
40.

RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.

Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E.

J Biol Chem. 1999 Apr 2;274(14):9472-8.

41.

Identification and characterization of RNA editing events within the 5-HT2C receptor.

Niswender CM, Sanders-Bush E, Emeson RB.

Ann N Y Acad Sci. 1998 Dec 15;861:38-48. Review.

PMID:
9928237
42.

A standardized nomenclature for adenosine deaminases that act on RNA.

Bass BL, Nishikura K, Keller W, Seeburg PH, Emeson RB, O'Connell MA, Samuel CE, Herbert A.

RNA. 1997 Sep;3(9):947-9. No abstract available.

43.

Regulation of serotonin-2C receptor G-protein coupling by RNA editing.

Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB.

Nature. 1997 May 15;387(6630):303-8.

PMID:
9153397
44.

Structure and localization of the rabbit prostaglandin EP3 receptor.

Breyer RM, Emeson RB, Davis LS, Breyer MD.

Adv Exp Med Biol. 1997;400A:261-8. No abstract available.

PMID:
9547567
45.

Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.

Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E.

Mol Pharmacol. 1996 Oct;50(4):799-807.

PMID:
8863824
46.

RNA editing.

Simpson L, Emeson RB.

Annu Rev Neurosci. 1996;19:27-52. Review.

PMID:
8833435
47.

Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine.

Rueter SM, Burns CM, Coode SA, Mookherjee P, Emeson RB.

Science. 1995 Mar 10;267(5203):1491-4.

PMID:
7878468
48.

Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor.

Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, Abromson RM, Ferrenbach SM.

J Biol Chem. 1994 Feb 25;269(8):6163-9.

49.

Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements.

Yeakley JM, Hedjran F, Morfin JP, Merillat N, Rosenfeld MG, Emeson RB.

Mol Cell Biol. 1993 Oct;13(10):5999-6011.

50.

Calcitonin gene-related peptide: a neuropeptide generated as a consequence of tissue-specific, developmentally regulated alternative RNA processing events.

Rosenfeld MG, Emeson RB, Yeakley JM, Merillat N, Hedjran F, Lenz J, Delsert C.

Ann N Y Acad Sci. 1992 Jun 30;657:1-17. Review. No abstract available.

PMID:
1637077

Supplemental Content

Loading ...
Support Center